BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
7.69
+0.06 (0.79%)
At close: Nov 6, 2026, 4:00 PM EST
7.71
+0.02 (0.26%)
After-hours: Nov 6, 2026, 7:30 PM EST
BioCryst Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 96.97 | 89.74 | 104.71 | 110.64 | 304.77 | 504.39 |
Short-Term Investments | 278.03 | 185.01 | 216.14 | 278.34 | 119.54 | 3.21 |
Cash & Short-Term Investments | 375 | 274.75 | 320.85 | 388.99 | 424.31 | 507.6 |
Cash Growth | 76.16% | -14.37% | -17.52% | -8.33% | -16.41% | 68.99% |
Receivables | 121.79 | 106.82 | 79.07 | 56.95 | 50.6 | 29.41 |
Inventory | 13.74 | 5.4 | 8.09 | 28.68 | 27.53 | 15.79 |
Prepaid Expenses | 20.11 | 17.18 | 13.75 | 19.54 | 12.59 | 9.99 |
Restricted Cash | 0.52 | 0.2 | 0.21 | 1.8 | 1.47 | 3.35 |
Total Current Assets | 531.15 | 404.35 | 421.97 | 495.97 | 516.5 | 566.14 |
Property, Plant & Equipment | 7.48 | 18.99 | 19.79 | 20.91 | 15.42 | 15.19 |
Long-Term Investments | - | 61.16 | 20.32 | - | 18.08 | 6.83 |
Other Long-Term Assets | 52.44 | 29.66 | 28.34 | 0.08 | - | - |
Total Assets | 591.07 | 514.16 | 490.42 | 516.96 | 550 | 588.15 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 14.58 | 15.83 | 11.64 | 20.89 | 14.36 | 27.81 |
Accrued Expenses | 110.69 | 126.41 | 113.29 | 102.88 | 87.57 | 72.67 |
Current Portion of Long-Term Debt | 43.75 | 38.46 | 32.68 | 23.57 | - | - |
Current Portion of Leases | 3.44 | 1.63 | 2.77 | 2.65 | 2.37 | 1.82 |
Current Unearned Revenue | 10.54 | - | - | - | 1.22 | 1.42 |
Other Current Liabilities | 12.84 | 13.74 | - | - | - | - |
Total Current Liabilities | 195.83 | 196.07 | 160.38 | 149.99 | 105.51 | 103.72 |
Long-Term Debt | 773.55 | 427.23 | 795.92 | 811.27 | 733.28 | 585.46 |
Long-Term Leases | 7.46 | 10.01 | 10.05 | 11.24 | 5.8 | 5.96 |
Long-Term Unearned Revenue | 11.61 | - | - | - | - | - |
Total Liabilities | 988.45 | 633.31 | 966.35 | 972.49 | 844.6 | 695.14 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2.56 | 2.13 | 2.09 | 2.06 | 1.88 | 1.84 |
Additional Paid-In Capital | 1,712 | 1,385 | 1,291 | 1,222 | 1,158 | 1,098 |
Retained Earnings | -2,112 | -1,506 | -1,770 | -1,681 | -1,455 | -1,208 |
Comprehensive Income & Other | -0.61 | 0.04 | 0.92 | 1.34 | 0.03 | 0.18 |
Shareholders' Equity | -397.38 | -119.15 | -475.93 | -455.53 | -294.6 | -106.99 |
Total Liabilities & Equity | 591.07 | 514.16 | 490.42 | 516.96 | 550 | 588.15 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 828.2 | 477.33 | 841.42 | 848.71 | 741.45 | 593.24 |
Net Cash (Debt) | -453.2 | -202.58 | -520.57 | -459.73 | -317.14 | -85.64 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.88 | -0.93 | -2.52 | -2.39 | -1.71 | -0.48 |
Filing Date Shares Outstanding | 257.3 | 250.8 | 208.96 | 206.15 | 188.45 | 184.66 |
Total Common Shares Outstanding | 256.12 | 213.06 | 208.54 | 205.77 | 187.91 | 184.35 |
Working Capital | 335.32 | 208.28 | 261.58 | 345.98 | 410.99 | 462.42 |
Book Value Per Share | -1.55 | -0.56 | -2.28 | -2.21 | -1.57 | -0.58 |
Tangible Book Value | -397.38 | -119.15 | -475.93 | -455.53 | -294.6 | -106.99 |
Tangible Book Value Per Share | -1.55 | -0.56 | -2.28 | -2.21 | -1.57 | -0.58 |
Machinery | - | 7.41 | 8.41 | 7.66 | 6.53 | 5.84 |
Construction In Progress | - | - | 0.1 | - | - | - |
Leasehold Improvements | - | 10.44 | 10.36 | 10.21 | 10.14 | 9.83 |